Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Hadassah Welcomes New Head of Pediatrics at Ein Kerem Hospital

Dr. Shimon Reif

Professor Shimon Reif, a specialist in pediatrics and pediatric gastroenterology and Chair of the Pediatric Division at the Tel Aviv Sourasky Medical Center, has been appointed head of Pediatrics at Hadassah Hospital-Ein Kerem. He is replacing Prof. Dan Engelhard, who has completed 10 years in the role and will now continue to serve as head of Hadassah's Pediatric Infectious Diseases Unit and Pediatric AIDS Center.

A graduate of the School of Medicine at the Technion in Haifa, Prof. Reif served as a military field doctor in the Paratroopers Brigade of the Israel Defense Forces. The father of five children, he took his residency in pediatrics at the Sourasky Medical Center and specialized in pediatric gastroenterology at the Women and Children's Hospital of Buffalo, NY. Prof. Rief also did post-graduate work in the Division of Digestive Diseases at the University of North Carolina in Chapel Hill.

Serving as Secretary of Israel's Society for Liver Cancer and Secretary of Israel's Society of Clinical Pediatrics, Prof. Reif is also Chair of Israel's Association for Pediatric Gastroenterology and Nutrition and Associate Editor of the Journal of Pediatric Gastroenterology. Prof. Reif has published more than 100 articles in prestigious medical journals, such as Pediatric Medicine and Pediatric Gastroenterology and Liver Diseases. He is frequently called on to present his research at national and international professional conferences.

Click here for more news about Hadassah Medical Organization>>


Date: 1/9/2013


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America